MicroTransponder
MicroTransponder Inc., based in Austin, develops neurostimulation systems for stroke and tinnitus treatment, serving global medical communities.
Founded
2007MicroTransponder Inc., based in Austin, develops neurostimulation systems for stroke and tinnitus treatment, serving global medical communities.
MicroTransponder Inc., founded in Austin, Texas, is dedicated to developing innovative neurostimulation systems aimed at treating chronic neurological conditions such as stroke and tinnitus. The company's core mission is to enhance the quality of life for patients through advanced medical technology. Their flagship product, the Vivistim® Paired VNS™ System, combines Vagus Nerve Stimulation (VNS) with therapy to aid stroke patients in regaining motor function in their arms and hands, even years after the initial incident. MicroTransponder serves medical communities on a global scale.
Notable figures associated with MicroTransponder include leading neuroscientists and medical professionals who contribute to their research and development efforts. The company has garnered significant attention and investment from the medical device industry, bolstering its credibility and reach. Key achievements include FDA approval of the Vivistim System, marking a significant milestone in stroke rehabilitation technology. Overall, MicroTransponder has made a substantial impact on the field of neurostimulation, offering new hope and improved outcomes for patients with chronic neurological impairments.
Companies similar to MicroTransponder include Nexeon Medsystems, Scion Neurostim, Realeve and Micro-Leads.
MicroTransponder was founded in 2007.
MicroTransponder's headquarters is located in Austin, TX, US.
MicroTransponder's most recent funding round was for $65M (USD) in March 2025.
As of Mar 1, 2025, MicroTransponder has disclosed funding of $198.1M (USD). Undisclosed round amounts are excluded.
MicroTransponder has 74 employees as of Feb 5, 2024.
Micro-Leads
